Overview

Prevention of SARS-CoV-2 in Hospital Workers s Exposed to the Virus

Status:
Completed
Trial end date:
2020-06-18
Target enrollment:
Participant gender:
Summary
The Investigators propose to set up a preventive trial of infection in hospital workers at risk of coronavirus infection by comparing the rate of SARS-Cov-2 infection in a population of negative SARS-Cov-2 hospital workers receiving preventively azithromycin, hydroxychloroquine or a Placebo
Phase:
Phase 3
Details
Lead Sponsor:
Assistance Publique - Hôpitaux de Paris
Treatments:
Azithromycin
Hydroxychloroquine